Out-of-pocket Spending on Orphan Drug Prescriptions Among Commercially Insured Adults in 2014

被引:6
作者
Chua, Kao-Ping [1 ]
Conti, Rena M. [2 ,3 ]
机构
[1] Univ Michigan, Sch Med, Child Hlth Evaluat & Res Ctr, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA
[2] Boston Univ, Questrom Sch Business, Dept Markets Publ Policy & Law, Boston, MA 02215 USA
[3] Boston Univ, Questrom Sch Business, Inst Hlth Syst Innovat & Policy, Boston, MA 02215 USA
关键词
D O I
10.1007/s11606-018-4694-1
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
引用
收藏
页码:338 / 340
页数:3
相关论文
共 6 条
[1]  
[Anonymous], ORPH DRUGS US PROV C
[2]   Cost Sharing and Adherence to Tyrosine Kinase Inhibitors for Patients With Chronic Myeloid Leukemia [J].
Dusetzina, Stacie B. ;
Winn, Aaron N. ;
Abel, Gregory A. ;
Huskamp, Haiden A. ;
Keating, Nancy L. .
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04) :306-311
[3]  
Faden L, 2010, RARE DIS ORPHAN PROD
[4]  
FDA, 2017, ORPH DRUG DES APPR
[5]  
Hansen LG., 2011, HLTH RES DATA REAL W
[6]  
Kasier Family Foundation, 2016, EX HIGH PRESCR DRUG